Genetic progression model for head and neck cancer: Implications for field cancerization

被引:3
作者
Califano, J
vanderRiet, P
Westra, W
Nawroz, H
Clayman, G
Piantadosi, S
Corio, R
Lee, D
Greenberg, B
Koch, W
Sidransky, D
机构
[1] JOHNS HOPKINS UNIV HOSP,DEPT OTOLARYNGOL HEAD & NECK SURG,BALTIMORE,MD 21205
[2] JOHNS HOPKINS UNIV HOSP,DEPT ONCOL,BALTIMORE,MD 21205
[3] JOHNS HOPKINS UNIV HOSP,DEPT BIOSTAT,BALTIMORE,MD 21205
[4] JOHNS HOPKINS UNIV HOSP,DEPT PATHOL,BALTIMORE,MD 21205
[5] MD ANDERSON CANC CTR,HOUSTON,TX 77030
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A genetic progression model of head and neck squamous cell carcinoma has not yet been elucidated, and the genetic basis for ''field cancerization'' of the aerodigestive tract has also remained obscure, Eighty-seven lesions of the head and neck, including preinvasive lesions and benign lesions associated with carcinogen exposure, were tested using microsatellite analysis for allelic loss at 10 major chromosomal loci which have been defined previously, The spectrum of chromosomal loss progressively increased at each histopathological step from benign hyperplasia to dysplasia to carcinoma in situ to invasive cancer, Adjacent areas of tissue with different histopathological appearance shared common genetic changes, but the more histopathologically advanced areas exhibited additional genetic alterations, Abnormal mucosal cells surrounding preinvasive and microinvasive lesions shared common genetic alterations with those lesions and thus appear to arise from a single progenitor clone, Based on these findings, the local clinical phenomenon of field cancerization seems to involve the expansion and migration of clonally related preneoplastic cells.
引用
收藏
页码:2488 / 2492
页数:5
相关论文
共 40 条
[1]  
BAKER SJ, 1990, CANCER RES, V50, P7717
[2]  
Bedi GC, 1996, CANCER RES, V56, P2484
[3]   MICROALLELOTYPING DEFINES THE SEQUENCE AND TEMPO OF ALLELIC LOSSES AT TUMOR-SUPPRESSOR GENE LOCI DURING COLORECTAL-CANCER PROGRESSION [J].
BOLAND, CR ;
SATO, J ;
APPELMAN, HD ;
BRESALIER, RS ;
FEINBERG, AP .
NATURE MEDICINE, 1995, 1 (09) :902-909
[4]  
BOYLE JO, 1993, CANCER RES, V53, P4477
[5]   MOLECULAR ASSESSMENT OF HISTOPATHOLOGICAL STAGING IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK [J].
BRENNAN, JA ;
MAO, L ;
HRUBAN, RH ;
BOYLE, JO ;
EBY, YJ ;
KOCH, WM ;
GOODMAN, SN ;
SIDRANSKY, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (07) :429-435
[6]  
CALLENDER T, 1994, CANCER-AM CANCER SOC, V74, P152, DOI 10.1002/1097-0142(19940701)74:1<152::AID-CNCR2820740124>3.0.CO
[7]  
2-K
[8]  
CHRISTENSEN PH, 1987, LARYNGOSCOPE, V97, P612
[9]   2ND MALIGNANCIES IN PATIENTS WHO HAVE HEAD AND NECK-CANCER - INCIDENCE, EFFECT ON SURVIVAL AND IMPLICATIONS BASED ON THE RTOG EXPERIENCE [J].
COOPER, JS ;
PAJAK, TF ;
RUBIN, P ;
TUPCHONG, L ;
BRADY, LW ;
LEIBEL, SA ;
LARAMORE, GE ;
MARCIAL, VA ;
DAVIS, LW ;
COX, JD .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 17 (03) :449-456
[10]   CYTOGENETIC EVIDENCE OF THE MULTISTEP ORIGIN OF HEAD AND NECK SQUAMOUS-CELL CARCINOMAS [J].
COWAN, JM ;
BECKETT, MA ;
AHMEDSWAN, S ;
WEICHSELBAUM, RR .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (10) :793-797